65 Mary O’Brien et al., “SRL172 (Killed Mycobacterium vaccae) in Addition to Standard Chemotherapy Improves Quality of Life Without Affecting Survival, in Patients with Advanced Non-small-cell Lung Cancer: Phase III Results”, Annals of Oncology 15 (2004), 906–914.
65
Mycobacterium vaccae)
Annals of Oncology
66 John Stanford et al., “Successful Immunotherapy with Mycobacterium vaccae in the Treatment of Adenocarcinoma of the Lung”, European Journal of Cancer 44 (2008), 224–227.
66
Mycobacterium vaccae
European Journal of Cancer
67 11 апреля 2001 г. стоимость акций SR Pharma упала на 76,9 %. Это было самое сильное падение за этот день по данным индекса FTSE 100.
67
68 National Sweet Itch Centre, “Studies on the Prevention and Treatment of Sweet-Itch”, www.sweet-itch.co.uk/ trials.html.
68
69 Неопубликованные данные: John Stanford, Graham McIntyre (Centre for Infectious Diseases and International Health, University College London), 2006.
69
70 Claudia Zuany-Amorin et al., “Suppression of Airway Eosinophilia by Killed Mycobacterium vaccae-lnduced Allergen-Specific Regulatory T-cells”, Nature Medicine 8 (2002), 625–629; Victoria Adams et al., “Mycobacterium vaccae Induces a Population of Pulmonary CDiic (+) Cells with Regulatory Potential in Allergic Mice”, European Journal of Immunology 34 (2004), 631–638.
70
Mycobacterium vaccae-lnduced
Nature Medicine
“Mycobacterium vaccae
European Journal of Immunology